Nanobiosym
Company Details
Status: Private
Employees: 11-50
Location:
245 1st Street, Cambridge, MA 02142, US
Type:
sample
Technology:
sample
About: Nanobiosym is a Massachusetts-based innovation engine and research institute that combines physics, biomedicine, and nanotechnology to create solutions for global health, energy, and environmental challenges. Founded by Dr. Anita Goel, the company operates through its commercial arm, Nanobiosym Diagnostics (NBSDx), focusing on portable diagnostic technologies.
One of its key products is Gene-RADAR®, a portable platform that enables rapid and accurate detection of genetic fingerprints from pathogens, facilitating point-of-care diagnostics for diseases such as COVID-19. Nanobiosym also engages in research and incubation, developing technologies in mobile health, energy harvesting, and quantum computing. The Nanobiosym Global Initiative promotes public-private partnerships to deploy these technologies in underserved markets.
Recognized as a top science innovator, Nanobiosym has received awards from various organizations, including DARPA and the XPRIZE Foundation. The company aims to democratize access to healthcare and sustainable solutions, targeting global health systems, governments, NGOs, and academic partners for collaboration.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Nanobiosym | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.